Market Overview

Seattle Genetics, Inc. (NASDAQ: SGEN)

199.91 +1.69 (0.85%)

Analyst Ratings

DateResearch FirmActionCurrentPT
10/15/20B of A SecuritiesMaintainsNeutral215.0
10/12/20SVB LeerinkMaintainsOutperform204.0
9/22/20SVB LeerinkMaintainsOutperform187.0
9/15/20RBC CapitalMaintainsOutperform191.0
9/15/20Morgan StanleyMaintainsEqual-Weight167.0
9/15/20SVB LeerinkMaintainsOutperform185.0
7/31/20Morgan StanleyMaintainsEqual-Weight160.0
7/31/20SVB LeerinkMaintainsOutperform173.0
7/31/20HC Wainwright & Co.MaintainsBuy200.0
7/24/20Piper SandlerDowngradesNeutral165.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter